KOMBIGLYZE XR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Saxagliptin Hydrochloride; Metformin Hydrochloride.
Product ID | 0310-6135_1e7f37ed-134a-456b-a759-dffd0dbf1360 |
NDC | 0310-6135 |
Product Type | Human Prescription Drug |
Proprietary Name | KOMBIGLYZE XR |
Generic Name | Saxagliptin And Metformin Hydrochloride |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2014-12-04 |
Marketing Category | NDA / NDA |
Application Number | NDA200678 |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | SAXAGLIPTIN HYDROCHLORIDE; METFORMIN HYDROCHLORIDE |
Active Ingredient Strength | 5 mg/1; mg/1 |
Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA],Biguanide [EPC],Biguanides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2015-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA200678 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-01-01 |
Marketing Category | NDA |
Application Number | NDA200678 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-01-01 |
Ingredient | Strength |
---|---|
SAXAGLIPTIN HYDROCHLORIDE | 5 mg/1 |
SPL SET ID: | fbd25da4-ebe6-45c9-beb8-93523d11a0b4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0310-6125 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
0310-6135 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
0310-6145 | KOMBIGLYZE | SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KOMBIGLYZE 85141038 4301782 Live/Registered |
ASTRAZENECA AB 2010-09-29 |